Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 229

Results For "X"

9473 News Found

Freudenberg Medical launches CleanAssure cleanroom for sterile single-use assemblies
News | April 22, 2026

Freudenberg Medical launches CleanAssure cleanroom for sterile single-use assemblies

It is actually a new ISO Class 5 controlled cleanroom designed to deliver washed, dried, and gamma-sterilized single-use assemblies ready for immediate use.


Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%
Sustainability | April 22, 2026

Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%

Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials


Supriya Lifescience receives USFDA EIR with VAI classification for Maharashtra API facility
News | April 22, 2026

Supriya Lifescience receives USFDA EIR with VAI classification for Maharashtra API facility

Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States


Former VP M. Venkaiah Naidu praises Wadi Surgicals infrastructure in AMTZ, Visakhapatnam
Medical Device | April 22, 2026

Former VP M. Venkaiah Naidu praises Wadi Surgicals infrastructure in AMTZ, Visakhapatnam

The plant is currently scaling towards a production capacity of nearly 3 million gloves per day


Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%
Clinical Trials | April 22, 2026

Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%

The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints


Moderna launches late-stage trial of mRNA bird flu vaccine
Clinical Trials | April 22, 2026

Moderna launches late-stage trial of mRNA bird flu vaccine

The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone


ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche
Clinical Trials | April 22, 2026

ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche

The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents


Moderna wins EU approval for first combined flu & COVID shot for adults 50+
Drug Approval | April 22, 2026

Moderna wins EU approval for first combined flu & COVID shot for adults 50+

The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states


Samsung Bioepis unveils promising preclinical data for novel ADC SBE303 at AACR 2026
Biopharma | April 21, 2026

Samsung Bioepis unveils promising preclinical data for novel ADC SBE303 at AACR 2026

SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers


HCG Cancer Hospital, Borivali hosts ROBOCAN 1.0 to advance robotic cancer surgery adoption
Hospitals | April 21, 2026

HCG Cancer Hospital, Borivali hosts ROBOCAN 1.0 to advance robotic cancer surgery adoption

Experts highlighted how robotic-assisted procedures are improving surgical precision, reducing complications, and enabling faster recovery